Zobrazeno 1 - 10
of 199
pro vyhledávání: '"Nishidate M"'
Autor:
Mitsunaga S; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.; Division of Biomarker Discovery, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan., Ikeda M; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Imaoka H; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Sasaki M; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Watanabe K; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Sato A; Clinical Research Support Office, National Cancer Center Hospital East, Kashiwa, Japan., Aoki K; Division of Molecular and Cellular Medicine, National Cancer Center, Kashiwa, Japan., Ochiai A; Division of Biomarker Discovery, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan., Makikawa M; Pharmaceutical Science Department, Chugai Pharmaceutical Co. Ltd., Tokyo, Japan., Nishidate M; Pharmaceutical Science Department, Chugai Pharmaceutical Co. Ltd., Tokyo, Japan., Yamaguchi K; Pharmaceutical Science Department, Chugai Pharmaceutical Co. Ltd., Tokyo, Japan., Terao K; Pharmaceutical Science Department, Chugai Pharmaceutical Co. Ltd., Tokyo, Japan., Sawada N; Discovery Pharmacology Department, Chugai Pharmaceutical Co. Ltd., Tokyo, Japan., Fujitomo T; Discovery Technology Department, Chugai Pharmaceutical Co. Ltd., Tokyo, Japan., Fujii E; Pharmaceutical Science Department, Chugai Pharmaceutical Co. Ltd., Tokyo, Japan.; Non-clinical Safety Assessment Department, Chugai Pharmaceutical Co. Ltd., Tokyo, Japan., Kato A; Non-clinical Safety Assessment Department, Chugai Pharmaceutical Co. Ltd., Tokyo, Japan., Tsunoda H; Discovery Technology Department, Chugai Pharmaceutical Co. Ltd., Tokyo, Japan.
Publikováno v:
Cancer science [Cancer Sci] 2023 Oct; Vol. 114 (10), pp. 4006-4019. Date of Electronic Publication: 2023 Aug 21.
Autor:
Nishidate M; Pharmaceutical Science Dept., Chugai Pharmaceutical Co., Ltd, Kamakura, Kanagawa, 247-8530, Japan., Shibahara N; Pharmaceutical Science Dept., Chugai Pharmaceutical Co., Ltd, Gotemba, Shizuoka, 412-8513, Japan., Hayasaka A; Discovery Biologics Dept., Chugai Pharmaceutical Co., Ltd, Gotemba, Shizuoka, 412-8513, Japan., Staack RF; Roche Pharma Research & Early Development (pRED), Pharmaceutical Sciences, Bioanalytical R&D, Roche Innovation Center Munich, Roche Diagnostics GmbH, Penzberg, 82377, Germany., Miyayama T; Pharmaceutical Science Dept., Chugai Pharmaceutical Co., Ltd, Kamakura, Kanagawa, 247-8530, Japan., Terao K; Pharmaceutical Science Dept., Chugai Pharmaceutical Co., Ltd, Kamakura, Kanagawa, 247-8530, Japan., Jordan G; Roche Pharma Research & Early Development (pRED), Pharmaceutical Sciences, Bioanalytical R&D, Roche Innovation Center Munich, Roche Diagnostics GmbH, Penzberg, 82377, Germany.
Publikováno v:
Bioanalysis [Bioanalysis] 2022 Jul; Vol. 14 (13), pp. 935-947. Date of Electronic Publication: 2022 Jul 29.
Autor:
Solon E; Member of Executive Committee, Imaging Mass Spectrometry Society (IMSS), Madrigal Pharmaceuticals, Inc., Four Tower Bridge, 200 Barr Harbor Drive, West Conshohocken, PA, 19428, USA. Electronic address: eric.solon@madrigalpharma.com., Groseclose MR; Member of Executive Committee, IMSS, GlaxoSmithKline, 1250 S, Collegeville Rd., Collegeville, PA, 19426, USA. Electronic address: reid.x.groseclose@gsk.com., Ho S; Member of Executive Committee, IMSS, Drug Metabolism and Pharmacokinetics, Pharmaceutical Sciences, Roche Innovation Center Shanghai (RICS), Building 5, No. 371, Lishizhen Road, Pudong New Area, Shanghai, China. Electronic address: stacy.ho@roche.com., Tanaka K; Member of Japan Association for Imaging Mass Spectrometry, DMPK Research Laboratories, Sohyaku. Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, 1000, Kamoshida-cho, Aoba-ku, Yokohama, Kanagawa, 227-0033, Japan. Electronic address: tanaka.kouji@ma.mt-pharma.co.jp., Nakada N; Member of Japan Association for Imaging Mass Spectrometry, Analysis&Pharmacokinetics Research Labs., Drug Discovery Research, Astellas Pharma Inc., 21, Miyukigaoka, Tsukuba, Ibaraki, 305-8585, Japan. Electronic address: naoyuki.nakada@astellas.com., Linehan S; Asia-Pacific (APAC) Outreach Liaison, IMSS Boston, MA, USA. Electronic address: stefan.linehan@gmail.com., Nishidate M; Member of Japan Association for Imaging Mass Spectrometry, Pharmaceutical Science Dept., Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa, 247-8530, Japan. Electronic address: nishidate.masanobu@chugai-pharm.co.jp., Yokoi H; Member of Japan Association for Imaging Mass Spectrometry, Drug Metabolism and Pharmacokinetics Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., 463-10 Kagasuno, Kawauchi-cho, Tokushima-shi, Tokushima, 771-0192, Japan. Electronic address: Yokoi.Hiroyuki@otsuka.jp., Kaji H; Member of Japan Association for Imaging Mass Spectrometry, Drug Development Service Segment, LSI Medience Corporation13-4, Uchikanda 1-chome, Chiyoda-ku, Tokyo, 101-8517, Japan. Electronic address: kaji.hidefumi@mh.medience.co.jp., Urasaki Y; Member of Japan Association for Imaging Mass Spectrometry, Drug Metabolism and Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58, Hiromachi, Shinagawa-ku, Tokyo, 140-8710, Japan. Electronic address: urasaki.yoko.j8@daiichisankyo.co.jp., Watanabe K; Member of Japan Association for Imaging Mass Spectrometry, Preclinical Research Unit, Sumitomo Dainippon Pharma Co.,Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka, 554-0022, Japan. Electronic address: kenichi-watanabe@ds-pharma.co.jp., Ishida T; Member of Japan Association for Imaging Mass Spectrometry, Global Drug Metabolism and Pharmacokinetics, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki, 300-2635, Japan. Electronic address: t6-ishida@hhc.eisai.co.jp., Komatsu R; Member of Japan Association for Imaging Mass Spectrometry, Laboratory for Drug Discovery Pharmaceuticals Research Center, Asahi Kasei Pharma Corporation.632-1 Mifuku, Izunokuni, Shizuoka, 410-2321, Japan. Electronic address: harada.rb@om.asahi-kasei.co.jp., Yoshida K; Member of Japan Association for Imaging Mass Spectrometry, Drug Development Solutions Planning Department, Pharmaceutical Sciences Division, Sekisuimedical Co., Ltd., 2117 Muramatsu, Tokai, Ibaraki, 319-1182. Electronic address: kenji.yoshida@sekisui.com., Yamazaki H; Member of Japan Association for Imaging Mass Spectrometry, Showa Pharmaceutical University, 3-3165 Higashi-tamagawa Gakuen, Machida, Tokyo, 194-8543, Japan. Electronic address: hyamazak@ac.shoyaku.ac.jp., Saito K; Member of Japan Association for Imaging Mass Spectrometry, Division of Medicinal Safety Science, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, 210-9501, Japan. Electronic address: saitok2@nihs.go.jp., Saito Y; Member of Japan Association for Imaging Mass Spectrometry, Division of Medicinal Safety Science, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, 210-9501, Japan. Electronic address: yoshiro@nihs.go.jp., Tanaka Y; Leader of Japan Association for Imaging Mass Spectrometry, Drug Metabolism and Pharmacokinetics, Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd., 3-1-1, Futaba, Toyonaka, Osaka, 561-0825, Japan. Electronic address: yukari.tanaka@shionogi.co.jp.
Publikováno v:
Drug metabolism and pharmacokinetics [Drug Metab Pharmacokinet] 2022 Apr; Vol. 43, pp. 100438. Date of Electronic Publication: 2021 Dec 16.
Autor:
Yu, Shuhong1 (AUTHOR), Wang, Siyu1 (AUTHOR), Wang, Xuanyu2 (AUTHOR), Xu, Ximing1 (AUTHOR) doctorxu120@aliyun.com
Publikováno v:
Cancer Cell International. 10/7/2024, Vol. 24 Issue 1, p1-30. 30p.
Applications of MALDI mass spectrometry imaging for pharmacokinetic studies during drug development.
Autor:
Nishidate M; Clinical Pharmacology Dept., Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura-shi, Kanagawa, 247-8530, Japan., Hayashi M; Division of Molecular Pharmacology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Aikawa H; Division of Molecular Pharmacology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Tanaka K; DMPK Research Laboratories, Sohyaku. Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, 2-2-50 Kawagishi, Toda-shi, Saitama, 335-8505, Japan., Nakada N; Analysis & Pharmacokinetics Research Labs., Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka Tsukuba-shi, Ibaraki, 305-8585, Japan., Miura SI; External Affairs Department, Daiichi Sankyo Co., Ltd., 3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, 103-8426, Japan., Ryu S; Division of Molecular Pharmacology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Higashi T; Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda-shi, Chiba, 278-8510, Japan., Ikarashi Y; Office of New Drug V, Pharmaceuticals and Medical Devices Agency, 3-2-2, Kasumigaseki, Chiyoda-ku, Tokyo, 100-0013, Japan., Fujiwara Y; Strategic Planning Bureau, National, Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Hamada A; Division of Molecular Pharmacology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan; Department of Pharmacology and Therapeutics, Fundamental Innovative Oncology Core, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. Electronic address: akhamad@ncc.go.jp.
Publikováno v:
Drug metabolism and pharmacokinetics [Drug Metab Pharmacokinet] 2019 Aug; Vol. 34 (4), pp. 209-216. Date of Electronic Publication: 2019 Apr 24.
Autor:
Niimi S; Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku Kawasaki-shi, Kanagawa, 210-9501, Japan. Electronic address: niimi19551113@gmail.com., Nishimiya K; Chugai Pharmaceutical Co., Ltd, 200 Kajiwara, Kamakura City, Kanagawa, 247-8530, Japan., Nishidate M; Chugai Pharmaceutical Co., Ltd, 200 Kajiwara, Kamakura City, Kanagawa, 247-8530, Japan., Saito T; Astellas Pharma Inc., 21 Miyukigaoka, Tsukubashi, Ibaraki, 305-8585, Japan., Minoura K; Astellas Pharma Inc., 21 Miyukigaoka, Tsukubashi, Ibaraki, 305-8585, Japan., Kadotsuji K; Sumitomo Dainippon Pharma Co., Ltd, 33-94 Enokicho, Suita-shi, Osaka, 554-0022, Japan., Shimakura J; Sumitomo Dainippon Pharma Co., Ltd, 1-13-1 Kyobashi, Chuo-ku, Tokyo, 104-8356, Japan., Shigemizu H; CMIC Pharma Science Co., Ltd, Formerly JCL Bioassay Corporation, 17-18, Nakahata-cho, Nishiwaki-shi, Hyogo, 677-0032, Japan., Hosogi J; Kyowa Hakko Kirin Co., Ltd, 1188, Shimotogari, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-9731, Japan., Adachi M; Kyowa Hakko Kirin Co., Ltd, 1188, Shimotogari, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-9731, Japan., Hashimoto T; LSI Medience Corporation, 30-1, Shimura 3-chome, Itabashi-ku, Tokyo, 174-8555, Japan., Mori T; LSI Medience Corporation, 30-1, Shimura 3-chome, Itabashi-ku, Tokyo, 174-8555, Japan., Harada H; LSI Medience Corporation, 14-1 Sunayama, Kamisu, Ibaraki, 314-0255, Japan., Yamamoto KI; LSI Medience Corporation, 1285 Kurisaki-machi, Uto, Kumamoto, 869-0425, Japan., Nakamura T; Shin Nippon Biomedicals Laboratories, Ltd, 2438 Miyanoura, Kagoshima, 891-1394, Japan., Nomura T; Shin Nippon Biomedicals Laboratories, Ltd, 2438 Miyanoura, Kagoshima, 891-1394, Japan., Yamaguchi I; Sumika Chemical Analysis Service, Ltd, 3-1-135 Kasugadenaka, Konohana-ku, Osaka, 554-0022, Japan., Sonehara K; Sumika Chemical Analysis Service, Ltd, 3-1-135 Kasugadenaka, Konohana-ku, Osaka, 554-0022, Japan., Ishii-Watabe A; Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku Kawasaki-shi, Kanagawa, 210-9501, Japan., Kawasaki N; Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku Kawasaki-shi, Kanagawa, 210-9501, Japan; Graduate School of Medical Life Science, Yokohama City University, 1-7-29 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.
Publikováno v:
Drug metabolism and pharmacokinetics [Drug Metab Pharmacokinet] 2018 Apr; Vol. 33 (2), pp. 125-132. Date of Electronic Publication: 2018 Mar 08.
Autor:
Khalikova M; Department of Analytical Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic.; Department of Chemistry, Faculty of Science, University of Hradec Králové, Hradec Králové, Czech Republic., Jireš J; Department of Analytical Chemistry, Faculty of Chemical Engineering, UCT Prague, Prague, Czech Republic.; Department of Development, Zentiva, k. s., Praha, Praha, Czech Republic., Horáček O; Department of Pharmaceutical Chemistry and Pharmaceutical Analysis, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic., Douša M; Department of Development, Zentiva, k. s., Praha, Praha, Czech Republic., Kučera R; Department of Pharmaceutical Chemistry and Pharmaceutical Analysis, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic., Nováková L; Department of Analytical Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic.
Publikováno v:
Mass spectrometry reviews [Mass Spectrom Rev] 2024 May-Jun; Vol. 43 (3), pp. 560-609. Date of Electronic Publication: 2023 Jul 28.
Autor:
Nishidate M; Translational Clinical Research Science & Strategy Dept., Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa, 247-8530, Japan.; Department of Molecular Pharmacology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Department of Medical Oncology and Translational Research, Graduate school of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan., Yamamoto K; Product Research Dept., Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa, 247-8530, Japan., Masuda C; Product Research Dept., Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa, 247-8530, Japan., Aikawa H; Division of Clinical Pharmacology and Translational Research, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Hayashi M; Division of Clinical Pharmacology and Translational Research, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Department of Molecular Pharmacology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Kawanishi T; Translational Clinical Research Science & Strategy Dept., Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa, 247-8530, Japan., Hamada A; Division of Clinical Pharmacology and Translational Research, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. akhamad@ncc.go.jp.; Department of Molecular Pharmacology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. akhamad@ncc.go.jp.; Department of Medical Oncology and Translational Research, Graduate school of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan. akhamad@ncc.go.jp.
Publikováno v:
Scientific reports [Sci Rep] 2017 Dec 01; Vol. 7 (1), pp. 16763. Date of Electronic Publication: 2017 Dec 01.
Autor:
Zhang, Meng1 (AUTHOR) zhangmenghh945@163.com, Niu, Huazhou1 (AUTHOR), Li, Qingqing1 (AUTHOR), Jiao, Lili1 (AUTHOR), Li, Hui1 (AUTHOR) lihuiterrisa@163.com, Wu, Wei1 (AUTHOR) lihuiterrisa@163.com
Publikováno v:
Pharmaceuticals (14248247). Jan2024, Vol. 17 Issue 1, p38. 25p.
Autor:
Aikawa H; Division of Clinical Pharmacology and Translational Research, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan., Hayashi M; Division of Clinical Pharmacology and Translational Research, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.; Department of Molecular Imaging and Pharmacokinetics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan., Ryu S; Department of Molecular Imaging and Pharmacokinetics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan., Yamashita M; Department of Molecular Imaging and Pharmacokinetics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan., Ohtsuka N; Shimadzu Techno-Research Inc., 3-19-2, Minamirokugo, Ohta-ku, Tokyo 144-0045, Japan., Nishidate M; Department of Molecular Imaging and Pharmacokinetics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.; Translational Clinical Research Science &Strategy Dept., Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa 247-8530, Japan.; Department of Medical Oncology and Translational Research, Graduate school of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto 860-8556, Japan., Fujiwara Y; Strategic Planning Bureau, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan., Hamada A; Division of Clinical Pharmacology and Translational Research, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.; Department of Molecular Imaging and Pharmacokinetics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.; Department of Medical Oncology and Translational Research, Graduate school of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto 860-8556, Japan.
Publikováno v:
Scientific reports [Sci Rep] 2016 Mar 30; Vol. 6, pp. 23749. Date of Electronic Publication: 2016 Mar 30.